11β-hydroxysteroid dehydrogenase type 1 as a predictive biomarker for glucocorticoid treatment response in inflammatory myopathies.
- DOI
- 10.5114/fn.2026.163679
- Published
- 2026
- Container
- Folia neuropathologica
- Publisher
- Not recorded
- Open access
- no
Credibility signals
uncertain Score 51/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- supportingDirectory of Open Access Journals: A matching record was returned by DOAJ.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.5114/fn.2026.163679,
title = {11β-hydroxysteroid dehydrogenase type 1 as a predictive biomarker for glucocorticoid treatment response in inflammatory myopathies.},
author = {Kabli A and Bamaga A and Gasemaltayeb R and Karami M and Alkhotani A and Almansouri M and Noorwali H and Fadul M and Badahdah A and Mehboob R and Alqarni A and Khashoggi K and Alkhotani A and Fathaddin A and Hassan A and Waseem H and Kurdi M},
year = {2026},
journal = {Folia neuropathologica},
doi = {10.5114/fn.2026.163679},
url = {https://doi.org/10.5114/fn.2026.163679}
}RIS
TY - JOUR TI - 11β-hydroxysteroid dehydrogenase type 1 as a predictive biomarker for glucocorticoid treatment response in inflammatory myopathies. AU - Kabli A AU - Bamaga A AU - Gasemaltayeb R AU - Karami M AU - Alkhotani A AU - Almansouri M AU - Noorwali H AU - Fadul M AU - Badahdah A AU - Mehboob R AU - Alqarni A AU - Khashoggi K AU - Alkhotani A AU - Fathaddin A AU - Hassan A AU - Waseem H AU - Kurdi M PY - 2026 JO - Folia neuropathologica DO - 10.5114/fn.2026.163679 UR - https://doi.org/10.5114/fn.2026.163679 ER -
APA
A, K., A, B., R, G., M, K., A, A., M, A., H, N., M, F., A, B., R, M., A, A., K, K., A, A., A, F., A, H., H, W., & M, K. (2026). 11β-hydroxysteroid dehydrogenase type 1 as a predictive biomarker for glucocorticoid treatment response in inflammatory myopathies.. Folia neuropathologica. https://doi.org/10.5114/fn.2026.163679
Source records
- pubmed · retrieved 2026-11-10T14:01:09.255Z
- europe-pmc · retrieved 2026-11-10T14:01:09.245Z
- doaj · retrieved 2026-11-10T14:01:09.242Z